ESR2 and prostate carcinoma: Horvath et al. using different primary antibodies studied ERβ expression patterns in normal, hyperplastic, and prostate cancer; they found that ERβ is highly expressed in normal human prostate, majority in the basal compartments of the epithelium, while more than 75% of PCs did not express ERβ.